BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24824005)

  • 1. [Optimal duration and timing of adjuvant chemotherapy after resection for pancreatic ductal adenocarcinoma].
    Strobel O; Büchler MW
    Chirurg; 2014 Jun; 85(6):543. PubMed ID: 24824005
    [No Abstract]   [Full Text] [Related]  

  • 2. Timing versus duration of adjuvant therapy for pancreatic cancer: all the lessons we need in life are taught to us as children.
    Chan E; Berlin J
    J Clin Oncol; 2014 Feb; 32(6):487-8. PubMed ID: 24419124
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.
    Valle JW; Palmer D; Jackson R; Cox T; Neoptolemos JP; Ghaneh P; Rawcliffe CL; Bassi C; Stocken DD; Cunningham D; O'Reilly D; Goldstein D; Robinson BA; Karapetis C; Scarfe A; Lacaine F; Sand J; Izbicki JR; Mayerle J; Dervenis C; Oláh A; Butturini G; Lind PA; Middleton MR; Anthoney A; Sumpter K; Carter R; Büchler MW
    J Clin Oncol; 2014 Feb; 32(6):504-12. PubMed ID: 24419109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma.
    Matsumoto I; Tanaka M; Shirakawa S; Shinzeki M; Toyama H; Asari S; Goto T; Yamashita H; Ishida J; Ajiki T; Fukumoto T; Shimokawa M; Ku Y
    Ann Surg Oncol; 2015 Jul; 22(7):2408-15. PubMed ID: 25487967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
    Flaum N; Hubner RA; Valle JW; Amir E; McNamara MG
    J Surg Oncol; 2019 Jun; 119(7):932-940. PubMed ID: 30838647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [I. The Efficacy of Preoperative Adjuvant Treatment for Pancreatic Ductal Adenocarcinoma Based on the Resectability Criteria according to JPS 7th].
    Shinkai T; Kato H; Hayasaki A; Murata Y; Kishiwada M; Isaji S
    Gan To Kagaku Ryoho; 2017 Oct; 44(10):837-844. PubMed ID: 29066676
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution?
    Salvia R; Malleo G; Maggino L; Milella M; Bassi C
    Updates Surg; 2020 Jun; 72(2):321-324. PubMed ID: 32445032
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma in Elderly Patients: Special Reference to Postoperative Adjuvant Chemotherapy.
    Watanabe Y; Shinkawa T; Endo S; Abe Y; Nishihara K; Nakano T
    World J Surg; 2018 Aug; 42(8):2617-2626. PubMed ID: 29383429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
    Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
    World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Oncology in Pancreatic Cancer. From Surgery- to Genetic-Based Chemotherapy.
    Domínguez-Rosado I; Meléndez-Zajgla J
    Rev Invest Clin; 2020 Dec; 72(6):333-336. PubMed ID: 33057318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma".
    Zhang YY; Xu J; Yu XJ; Shi S
    Ann Surg; 2021 Dec; 274(6):e718. PubMed ID: 32482982
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to the Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma".
    Perri G; Katz MHG
    Ann Surg; 2021 Dec; 274(6):e718-e719. PubMed ID: 32404662
    [No Abstract]   [Full Text] [Related]  

  • 13. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.
    Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of Pancreatic Resection and Patient Outcomes: Is There a Difference?
    Vreeland TJ; Katz MHG
    Surg Clin North Am; 2018 Feb; 98(1):57-71. PubMed ID: 29191278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network meta-analysis of randomized controlled trials.
    Hu Q; Wang X; Chen Y; Li X; Cao P; Cao D
    Medicine (Baltimore); 2019 May; 98(21):e15761. PubMed ID: 31124963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-adjuvant chemotherapy CA19-9 levels predict prognosis in patients with pancreatic ductal adenocarcinoma: A retrospective cohort study.
    Imaoka H; Shimizu Y; Senda Y; Natsume S; Mizuno N; Hara K; Hijioka S; Hieda N; Tajika M; Tanaka T; Ishihara M; Niwa Y; Yamao K
    Pancreatology; 2016; 16(4):658-64. PubMed ID: 27178104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A commentary on "Postoperative outcomes in elderly patients undergoing pancreatic resection for pancreatic adenocarcinoma: A systematic review and meta-analysis" [Int. J. Surg. 2019, 72:59-68].
    Altoukhi KH; Morris DL
    Int J Surg; 2020 Jan; 73():87-88. PubMed ID: 31759117
    [No Abstract]   [Full Text] [Related]  

  • 19. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A commentary on "Postoperative outcomes in elderly patients undergoing pancreatic resection for pancreatic adenocarcinoma: A systematic review and meta-analysis" (Int J Surg 2019;72:59-68).
    Zhao S; Zhu Y; Ruan Z
    Int J Surg; 2019 Dec; 72():204-205. PubMed ID: 31756543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.